fundraising >
Loading...
Loading investors...
16,382 investors
16,382 investors |
Geography | Checks | Stages | Lead | Investment thesis | Value add | Typical terms | Socials | Reply rate | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
![]() | Cooper and Company | USA | N/A | 4. Scaling 3. Early Revenue | We invest in private equity and real estate. |
|
Send email
| ||||
![]() | Forty51 Ventures VC firm | Switzerland | N/A | 3. Early Revenue | We invest in biotech. |
|
Send email
| ||||
![]() | 79 Studios VC firm | USA | N/A | 3. Early Revenue | We invest in technology companies led by inspirational female founders. |
|
Send email
| ||||
![]() | VGC Partners
VC firm | USA Germany Netherlands UK | $200k to $12M | 3. Early Revenue 4. Scaling5. Growth | We invest in consumer, digital media and technology companies from Seed to Series B. EIS and non-EIS investment available. | As an institutional investor bridging the gap between private equity and venture capital, we offer hands-on capital where needed.
|
|
| |||
![]() | Cosmostation VC firm | UK | N/A | 3. Early Revenue | We invest in blockchain applications and software providing streamlined access to interchain solutions. |
|
Send email
| ||||
![]() | Compass Digital Ve...
| Canada USA | $1M to $5M | 2. Prototype 3. Early Revenue4. Scaling | We invest in food, retail tech, and hospitality tech with a product that is ready to pilot in client facing locations. | We offer startups the opportunity to pilot solutions in Compass Group’s operations with real users in real environments, and guide startups as they grow across our organization in the business and industry, education, and healthcare verticals.
|
|
Fill form
| |||
![]() | Cerity Partners | USA | min. $2M | 4. Scaling | We accelerate venture-stage startups across North America, partnering with corporations to align investments with strategic innovation goals. |
|
| ||||
![]() | Leta Capital
VC firm | Canada USA UK Israel | $500k to $5M | 3. Early Revenue 4. Scaling5. Growth | We invest in IT solutions for various sectors, based on deep R&D, which can make the existing market more efficient or even fundamentally change it, for example, business analytics, big data analysis, AI technologies, VR/AR/XR, optimization and automation of processes, business robotization. More than $50k/mo Net Revenue. | https://www.entrepreneur.com/starting-a-business/9-ways-a-venture-capitalist-can-and-should-help-startup/434578
|
|
| |||
![]() | Robert W. Baird & ... | China USA | N/A | 4. Scaling 3. Early Revenue | We invest in companies offering wealth management, capital markets, and asset management solutions. |
|
Send email
| ||||
![]() | Georgian
VC firm | Canada USA UK Israel | $25M to $75M | 4. Scaling 5. Growth6. Pre-IPO | We invest in high-growth software and technology companies that harness the power of data and trust.
We invest in B2B SaaS companies globally with >$6M ARR. Our thesis areas are trust, applied AI, immersive interfaces, web3 and purpose. |
|
| ||||
![]() | Entrepreneur Inves...
| France Belgium Germany Spain Italy | $2M to $10M | 5. Growth 6. Pre-IPO4. Scaling | We invest in Late Venture, Growth Capital and Buy-Out operations with investment tickets from €2M to €10M. |
|
Submit deck
| ||||
![]() | Accelia Capital VC firm | Canada | N/A | 3. Early Revenue | We invest in innovative companies with significant technological potential. |
|
Send email
| ||||
![]() | Modern Energy Mana... VC firm | UK USA | N/A | 4. Scaling | We invest in emerging energy technologies, focusing on renewable energy and environmental engineering. |
|
Send email
| ||||
![]() | Aurelien Capital P... | USA | N/A | 3. Early Revenue | We invest in various family-related ventures. |
|
Send email
| ||||
![]() | HashedHealth
| USA | $300k to $300k | 2. Prototype 1. Idea or Patent3. Early Revenue | We invest in blockchain, healthcare, ai | Provides venture studio support with hands-on product and blockchain development, go-to-market and regulatory guidance, recruitment of founding teams, and access to enterprise partners, investors, and a collaborative healthcare innovation network.
| We typically do not offer a fixed cash-for-equity deal, instead co-building healthcare ventures through a studio model where equity is custom-negotiated—often around 20%–50%—in exchange for early capital, full product development, strategic validation, and operational support. |
|
| ||
![]() | Solve FSHD | USA | N/A | 3. Early Revenue 4. Scaling | We invest in innovation and research to accelerate treatments for facioscapulohumeral muscular dystrophy. |
|
Send email
| ||||
![]() | JLABS @ TMC (Johns... | USA | N/A | 1. Idea or Patent 2. Prototype3. Early Revenue4. Scaling | We accelerate life sciences startups including pharmaceuticals, medical devices, digital health, and consumer health bridging r&d to commercialization | 1:1 mentorship and coaching from scientific and business experts; access to shared wet labs, offices, and specialized research equipment; investor introductions and networking; CEO roundtables and educational programming; preferred supplier and software discounts; marketing, media, and speaking opportunities; access to the JLABS member ecosystem and corporate expertise.
|
|
| |||
![]() | Hekovnik Startup S... | Slovenia | N/A | 3. Early Revenue | We invest in e-learning and education initiatives. | AI-powered coaching and strategic tools, data-driven operational optimization, advanced decision-making frameworks, and innovation and digital transformation support to help businesses scale.
|
|
Send email
| |||
![]() | The Conduit EIS Im... VC firm | UK | N/A | 3. Early Revenue 4. Scaling | We invest in a diverse portfolio of early and growth stage businesses, focusing on impact. |
|
Send email
| ||||
![]() | Stone Arch Group | USA | N/A | 3. Early Revenue | We invest in growth companies. |
|
Send email
| ||||

USA
Switzerland

Germany
Netherlands
UK

Canada

Israel
China

France
Belgium
Spain
Italy






Slovenia
